Medtronic plc, MDT is in the exchange NYSE and its industry is Medical Appliances & Equipment in the sector of Healthcare. Based in USA, Medtronic plc, MDT has a market cap of 120912.57. Since its IPO date on the 12/31/1981, Medtronic plc, MDT performance year to date is 14.05%. Today Medtronic plc, MDT has gained -0.70%, with a current price of 86.85.
Ownership of the company is 0.10% for insider ownership while institutional ownership is 84.80%. The management of the company have seen the company have a payout ratio of 43.80%. Return of assets are at *TBA, with return on investment at 5.40%.
In terms of debt levels and profit levels, Medtronic plc, MDT is seeing a long-term debt/equity of 0.59. While Total debt/equity is 0.63. With a profit margin of *TBA, this is combined with a gross margin of 68.30%, and operating margin of *TBA. Medtronic plc ability to meet debt levels, with a current ratio of 3, while the quick ratio is 2.5.
For the last year Medtronic plc, MDT has seen a EPS growth of 2.90%. A performance for the year of 22.01%. The 52-week high is -2.71%, and the 52-week low is 37.11%. The average volume for Medtronic plc, MDT is 3079000.
With a target price of 92.55, can Medtronic plc, MDT reach this target? Looking at the value indicators of Medtronic plc, MDT. Medtronic plc has a P/E of 34.96 and a forward P/E of 16.77. Perhaps the more useful indicator than P/E, is PEG which has a value of 4.31. Medtronic plc also has a P/S and a P/B of 4.19 and 2.38 respectively. For P/cash, Medtronic plc has a value of 9.44, while it is 46.5 for P/free cash flow.
At the current price of 86.85, Medtronic plc has a dividend yield of 1.98%. We see a return on equity of *TBA.
Looking more long-term Medtronic plc, is projected to get an EPS growth for the next five years of 8.11%. In the short-term an EPS growth of 11.21% in the next year is forecasted. This is after a EPS growth of 2.90% for this year and for the last five years a -2.60% growth has been seen.